{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:24:51Z","timestamp":1793316291798,"version":"4.5.0"},"reference-count":109,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020050","name":"Japan Intractable Diseases Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005927","name":"Daiichi Sankyo Foundation of Life Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005927","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.bbagen.2025.130772","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T19:03:07Z","timestamp":1739473387000},"page":"130772","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["The roles of intrinsically disordered proteins in neurodegeneration"],"prefix":"10.1016","volume":"1869","author":[{"given":"Kagistia Hana","family":"Utami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasue","family":"Mitsukura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Okano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2025.130772_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214050","article-title":"Intrinsically disordered proteins: an overview","volume":"23","author":"Trivedi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbagen.2025.130772_bb0010","doi-asserted-by":"crossref","DOI":"10.1007\/s12551-022-00968-0","article-title":"Intrinsically disordered proteins and proteins with intrinsically disordered regions in neurodegenerative diseases","volume":"14","author":"Coskuner-Weber","year":"2022","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.bbagen.2025.130772_bb0015","article-title":"The triple power of D3: Protein intrinsic disorder in degenerative diseases","volume":"19","author":"Uversky","year":"2014","journal-title":"Front. Biosci. (Landmark)"},{"key":"10.1016\/j.bbagen.2025.130772_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2015.00018","article-title":"Intrinsically disordered proteins and their (disordered) proteomes in neurodegenerative disorders","volume":"7","author":"Uversky","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbagen.2025.130772_bb0025","doi-asserted-by":"crossref","DOI":"10.1021\/cr500288y","article-title":"Introduction to intrinsically disordered proteins (IDPs)","volume":"114","author":"Uversky","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bbagen.2025.130772_bb0030","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-022-00821-7","article-title":"Intrinsically disordered proteins play diverse roles in cell signaling","volume":"20","author":"Bondos","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.bbagen.2025.130772_bb0035","doi-asserted-by":"crossref","DOI":"10.2741\/3594","article-title":"Intrinsic disorder in proteins associated with neurodegenerative diseases","volume":"14","author":"Uversky","year":"2009","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bbagen.2025.130772_bb0040","doi-asserted-by":"crossref","DOI":"10.1007\/s11011-021-00791-8","article-title":"Intrinsically disordered proteins identified in the aggregate proteome serve as biomarkers of neurodegeneration","volume":"37","author":"Ayyadevara","year":"2022","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.bbagen.2025.130772_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbapap.2019.07.013","article-title":"Application of native mass spectrometry in studying intrinsically disordered proteins: a special focus on neurodegenerative diseases","volume":"1867","author":"Mitra","year":"2019","journal-title":"Biochim. Biophys. Acta, Proteins Proteomics"},{"key":"10.1016\/j.bbagen.2025.130772_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167208","article-title":"AlphaFold and implications for intrinsically disordered proteins","volume":"433","author":"Ruff","year":"2021","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbagen.2025.130772_bb0055","article-title":"Systematic identification of conditionally folded intrinsically disordered regions by AlphaFold2","volume":"120","author":"Reid Alderson","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbagen.2025.130772_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/wcms.1685","article-title":"Rational drug design targeting intrinsically disordered proteins","volume":"13","author":"Wang","year":"2023","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"key":"10.1016\/j.bbagen.2025.130772_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/s44320-023-00005-6","article-title":"Systematic discovery of protein interaction interfaces using AlphaFold and experimental validation","volume":"20","author":"Lee","year":"2024","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.bbagen.2025.130772_bb0070","doi-asserted-by":"crossref","DOI":"10.1111\/febs.17084","article-title":"Intrinsically disordered Pseudomonas chaperone FapA slows down the fibrillation of major biofilm-forming functional amyloid FapC","volume":"291","author":"Byeon","year":"2024","journal-title":"FEBS J."},{"key":"10.1016\/j.bbagen.2025.130772_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126027","article-title":"Intrinsic disorder may drive the interaction of PROS1 and MERTK in uveal melanoma","volume":"250","author":"Djulbegovic","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbagen.2025.130772_bb0080","article-title":"Intrinsically disordered proteins studied by NMR spectroscopy","volume":"18","author":"Schiavina","year":"2024","journal-title":"J. Magn. Reson. Open"},{"key":"10.1016\/j.bbagen.2025.130772_bb0085","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jpcb.3c04052","article-title":"Delineating structural propensities of the 4E-BP2 protein via integrative modeling and clustering","volume":"127","author":"Tsangaris","year":"2023","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bbagen.2025.130772_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214498","article-title":"Protein misfolding and aggregation in the brain: common pathogenetic pathways in neurodegenerative and mental disorders","volume":"23","author":"Ochneva","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbagen.2025.130772_bb0095","doi-asserted-by":"crossref","DOI":"10.1021\/cr400713r","article-title":"Pathological unfoldomics of uncontrolled chaos: Intrinsically disordered proteins and human diseases","volume":"114","author":"Uversky","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bbagen.2025.130772_bb0100","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkad928","article-title":"DisProt in 2024: improving function annotation of intrinsically disordered proteins","volume":"52","author":"Aspromonte","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbagen.2025.130772_bb0105","doi-asserted-by":"crossref","DOI":"10.1021\/acs.chemrev.1c00774","article-title":"Conformational dynamics of intrinsically disordered proteins regulate biomolecular condensate chemistry","volume":"122","author":"Abyzov","year":"2022","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bbagen.2025.130772_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2023.102678","article-title":"Role of aberrant phase separation in pathological protein aggregation","volume":"82","author":"Chakraborty","year":"2023","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.bbagen.2025.130772_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.826719","article-title":"Liquid-liquid phase separation of TDP-43 and FUS in physiology and pathology of neurodegenerative diseases","volume":"9","author":"Carey","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bbagen.2025.130772_bb0120","doi-asserted-by":"crossref","DOI":"10.1186\/s43556-022-00075-2","article-title":"Post-translational modifications in liquid-liquid phase separation: a comprehensive review","volume":"3","author":"Li","year":"2022","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.bbagen.2025.130772_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpj.2022.09.031","article-title":"Phase separation in amino acid mixtures is governed by composition","volume":"121","author":"De Sancho","year":"2022","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbagen.2025.130772_bb0130","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-biophys-121219-081629","article-title":"Physical Principles Underlying the Complex Biology of Intracellular Phase Transitions","volume":"49","author":"Choi","year":"2020","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.bbagen.2025.130772_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41580-022-00558-8","article-title":"A guide to membraneless organelles and their various roles in gene regulation","volume":"24","author":"Hirose","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbagen.2025.130772_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/cells11132063","article-title":"Regulation of cellular ribonucleoprotein granules: from assembly to degradation via post-translational modification","volume":"11","author":"Jeon","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbagen.2025.130772_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.csbj.2021.06.042","article-title":"Insight into membraneless organelles and their associated proteins: drivers, clients and regulators","volume":"19","author":"Orti","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.bbagen.2025.130772_bb0150","article-title":"Protein conformation and biomolecular condensates","volume":"4","author":"Vazquez","year":"2022","journal-title":"Curr. Res. Struct. Biol."},{"key":"10.1016\/j.bbagen.2025.130772_bb0155","doi-asserted-by":"crossref","DOI":"10.1039\/D0SC04395H","article-title":"Sequestration within biomolecular condensates inhibits A\u03b2-42 amyloid formation","volume":"12","author":"K\u00fcffner","year":"2021","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bbagen.2025.130772_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.12.035","article-title":"Considerations and challenges in studying liquid-liquid phase separation and biomolecular condensates","volume":"176","author":"Alberti","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.bbagen.2025.130772_bb0165","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.16-14-04491.1996","article-title":"Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer\u2019s disease","volume":"16","author":"G\u00f3mez-Isla","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbagen.2025.130772_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2012.01.011","article-title":"Alzheimer\u2019s disease: Pathogenesis and prevention","volume":"8","author":"Braak","year":"2012","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbagen.2025.130772_bb0175","volume":"1","year":"2020","journal-title":"J. Exp. Neurol."},{"key":"10.1016\/j.bbagen.2025.130772_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.bbagen.2025.130772_bb0185","doi-asserted-by":"crossref","DOI":"10.31887\/DCNS.2004.6.3\/galexander","article-title":"Biology of Parkinson\u2019s disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder","volume":"6","author":"Alexander","year":"2004","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.bbagen.2025.130772_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/S0896-6273(00)81108-3","article-title":"From Charcot to SOD1: mechanisms of selective motor neuron death in ALS","volume":"24","author":"Cleveland","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.bbagen.2025.130772_bb0195","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease","volume":"85","author":"Reiner","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbagen.2025.130772_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2018.03.028","article-title":"Intrinsically disordered proteins link alternative splicing and post-translational modifications to complex cell signaling and regulation","volume":"430","author":"Zhou","year":"2018","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbagen.2025.130772_bb0205","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.R115.695056","article-title":"Modulation of intrinsically disordered protein function by post-translational modifications","volume":"291","author":"Bah","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2025.130772_bb0210","doi-asserted-by":"crossref","DOI":"10.3934\/Neuroscience.2021005","article-title":"The biological pathways of Alzheimer disease: a review","volume":"8","author":"Calabr\u00f2","year":"2021","journal-title":"AIMS Neurosci."},{"key":"10.1016\/j.bbagen.2025.130772_bb0215","doi-asserted-by":"crossref","DOI":"10.1038\/s41582-022-00749-z","article-title":"Synaptic degeneration in Alzheimer disease","volume":"19","author":"Tzioras","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbagen.2025.130772_bb0220","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-179928","article-title":"Amyloid accumulation and cognitive decline in clinically normal older individuals: implications for aging and early Alzheimer\u2019s disease","volume":"64","author":"Mormino","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbagen.2025.130772_bb0225","doi-asserted-by":"crossref","DOI":"10.1111\/j.1582-4934.2009.00609.x","article-title":"A\u03b2 aggregation and possible implications in Alzheimer\u2019s disease pathogenesis","volume":"13","author":"Bharadwaj","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbagen.2025.130772_bb0230","doi-asserted-by":"crossref","DOI":"10.1021\/bi00191a006","article-title":"Solution structure of residues 1\u201328 of the amyloid \u03b2-peptide","volume":"33","author":"Talafous","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2025.130772_bb0235","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/731526","article-title":"Structure and pathology of tau protein in Alzheimer disease","author":"Kolarova","year":"2012","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.bbagen.2025.130772_bb0240","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.83.11.4040","article-title":"Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (\u03c4)","volume":"83","author":"Wood","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbagen.2025.130772_bb0245","doi-asserted-by":"crossref","DOI":"10.1097\/00002093-198701030-00021","article-title":"Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (?)","volume":"1","author":"Wood","year":"1987","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.bbagen.2025.130772_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/0022-510X(86)90167-X","article-title":"Alzheimer\u2019s disease: tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments","volume":"76","author":"Delacourte","year":"1986","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbagen.2025.130772_bb0255","doi-asserted-by":"crossref","DOI":"10.1038\/s41582-023-00883-2","article-title":"Tau-targeting therapies for Alzheimer disease: current status and future directions","volume":"19","author":"Congdon","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbagen.2025.130772_bb0260","doi-asserted-by":"crossref","DOI":"10.2174\/092986708785909111","article-title":"Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease","volume":"15","author":"Gong","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbagen.2025.130772_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173554","article-title":"Alzheimer\u2019s disease: recent treatment strategies","volume":"887","author":"Vaz","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbagen.2025.130772_bb0270","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00480-0","article-title":"Liquid-liquid phase separation of the microtubule-binding repeats of the Alzheimer-related protein tau","volume":"8","author":"Ambadipudi","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbagen.2025.130772_bb0275","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201798049","article-title":"Tau protein liquid\u2013liquid phase separation can initiate tau aggregation","volume":"37","author":"Wegmann","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.bbagen.2025.130772_bb0280","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M105196200","article-title":"Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local \u03b2-structure","volume":"276","author":"Von Bergen","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2025.130772_bb0285","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms1255","article-title":"The acetylation of tau inhibits its function and promotes pathological tau aggregation","volume":"2","author":"Cohen","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbagen.2025.130772_bb0290","doi-asserted-by":"crossref","DOI":"10.1046\/j.1471-4159.2003.02287.x","article-title":"Pseudophosphorylation of tau protein alters its ability for self-aggregation","volume":"88","author":"Haase","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbagen.2025.130772_bb0295","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M117.794602","article-title":"An acetylation\u2013phosphorylation switch that regulates tau aggregation propensity and function","volume":"292","author":"Carlomagno","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2025.130772_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2015.12.002","article-title":"Glycation alter the process of tau phosphorylation to change tau isoforms aggregation property","volume":"1862","author":"Liu","year":"2016","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bbagen.2025.130772_bb0305","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-16580-3","article-title":"Liquid-liquid phase separation induces pathogenic tau conformations in vitro","volume":"11","author":"Kanaan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbagen.2025.130772_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2022.08.016","article-title":"Condensed-phase signaling can expand kinase specificity and respond to macromolecular crowding","volume":"82","author":"Sang","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbagen.2025.130772_bb0315","doi-asserted-by":"crossref","DOI":"10.1002\/mds.10140","article-title":"Pathophysiology of parkinsion\u2019s disease: from clinical neurology to basic neuroscience and back","volume":"17","author":"Bergman","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbagen.2025.130772_bb0320","article-title":"Pathophysiology of motor dysfunction in Parkinson\u2019s disease as the rationale for drug treatment and rehabilitation","volume":"2016","author":"Magrinelli","year":"2016","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.bbagen.2025.130772_bb0325","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2014.00087","article-title":"Involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of Parkinson\u2019s disease","volume":"6","author":"Benazzouz","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbagen.2025.130772_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2022.167714","article-title":"Functional and pathological effects of \u03b1-synuclein on synaptic SNARE complexes","volume":"435","author":"Gao","year":"2023","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbagen.2025.130772_bb0335","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-013-0182-9","article-title":"\u03b1-synuclein and mitochondria: partners in crime?","volume":"10","author":"Nakamura","year":"2013","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bbagen.2025.130772_bb0340","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-021-01288-2","article-title":"Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro","volume":"9","author":"Marotta","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbagen.2025.130772_bb0345","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-019-0329-1","article-title":"Alpha-synuclein structure and Parkinson\u2019s disease - lessons and emerging principles","volume":"14","author":"Meade","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbagen.2025.130772_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/cells11111732","article-title":"Alpha-synuclein aggregation pathway in Parkinson\u2019s disease: current status and novel therapeutic approaches","volume":"11","author":"Vidovi\u0107","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbagen.2025.130772_bb0355","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2202867","article-title":"Trial of Prasinezumab in early-stage Parkinson\u2019s disease","volume":"387","author":"Pagano","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagen.2025.130772_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbagen.2025.130772_bb0365","article-title":"The biological function of the Huntingtin protein and its relevance to Huntington\u2019s disease pathology","volume":"5","author":"Schulte","year":"2011","journal-title":"Curr. Trends Neurol."},{"key":"10.1016\/j.bbagen.2025.130772_bb0370","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2019.00309","article-title":"Untangling the conformational polymorphism of disordered proteins associated with neurodegeneration at the single-molecule level","volume":"12","author":"Birol","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bbagen.2025.130772_bb0375","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.182276099","article-title":"Huntington\u2019s disease age-of-onset linked to polyglutamine aggregation nucleation","volume":"99","author":"Chen","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbagen.2025.130772_bb0380","doi-asserted-by":"crossref","DOI":"10.1021\/jacs.7b06659","article-title":"Monomeric Huntingtin exon 1 has similar overall structural features for wild-type and pathological polyglutamine lengths","volume":"139","author":"Warner","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbagen.2025.130772_bb0385","doi-asserted-by":"crossref","DOI":"10.1038\/nrneurol.2011.153","article-title":"Clinical diagnosis and management of amyotrophic lateral sclerosis","volume":"7","author":"Hardiman","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbagen.2025.130772_bb0390","article-title":"The genetics of amyotrophic lateral sclerosis: current insights","author":"Kirby","year":"2016","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"10.1016\/j.bbagen.2025.130772_bb0395","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science (1979)"},{"key":"10.1016\/j.bbagen.2025.130772_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2022.01.007","article-title":"iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders","volume":"29","author":"Okano","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbagen.2025.130772_bb0405","article-title":"Study protocol for a phase I\/IIa, double-blind, placebo-controlled trial of ropinirole for ALS","volume":"59","author":"Takahashi","year":"2019","journal-title":"Clin. Neurol."},{"key":"10.1016\/j.bbagen.2025.130772_bb0410","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-018-0140-5","article-title":"Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent","volume":"24","author":"Fujimori","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbagen.2025.130772_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2023.04.017","article-title":"Phase 1\/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery","volume":"30","author":"Morimoto","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbagen.2025.130772_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2014.03.019","article-title":"Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons","volume":"7","author":"Wainger","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbagen.2025.130772_bb0425","doi-asserted-by":"crossref","DOI":"10.1038\/s12276-020-00513-7","article-title":"The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies","volume":"52","author":"Jo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbagen.2025.130772_bb0430","doi-asserted-by":"crossref","DOI":"10.14336\/AD.2023.1118","article-title":"Molecular mechanisms of phase separation and amyloidosis of ALS\/FTD-linked FUS and TDP-43","volume":"15","author":"Song","year":"2024","journal-title":"Aging Dis."},{"key":"10.1016\/j.bbagen.2025.130772_bb0435","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.038950","article-title":"Structural determinants of the cellular localization and shuttling of TDP-43","volume":"121","author":"Ayala","year":"2008","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbagen.2025.130772_bb0440","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.69.6.3584-3596.1995","article-title":"Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs","volume":"69","author":"Ou","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.bbagen.2025.130772_bb0445","doi-asserted-by":"crossref","DOI":"10.1038\/nrn3121","article-title":"Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration","volume":"13","author":"Lee","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbagen.2025.130772_bb0450","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.13625","article-title":"Physiological functions and pathobiology of TDP-43 and FUS\/TLS proteins","author":"Ratti","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbagen.2025.130772_bb0455","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2019.00301","article-title":"Structural insights into TDP-43 and effects of post-translational modifications","volume":"12","author":"Fran\u00e7ois-Moutal","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bbagen.2025.130772_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2015.08.018","article-title":"Formation and maturation of phase-separated liquid droplets by RNA-binding proteins","volume":"60","author":"Lin","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbagen.2025.130772_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2018.07.002","article-title":"Poly(ADP-ribose) prevents pathological phase separation of TDP-43 by promoting liquid demixing and stress granule localization","volume":"71","author":"McGurk","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbagen.2025.130772_bb0470","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkae655","article-title":"Stress granule formation helps to mitigate neurodegeneration","volume":"52","author":"Glineburg","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbagen.2025.130772_bb0475","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1242925","article-title":"Phase separation and pathologic transitions of RNP condensates in neurons: implications for amyotrophic lateral sclerosis, frontotemporal dementia and other neurodegenerative disorders","volume":"16","author":"Naskar","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bbagen.2025.130772_bb0480","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.69377","article-title":"HspB8 prevents aberrant phase transitions of FUS by chaperoning its folded RNA binding domain","volume":"10","author":"Boczek","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.bbagen.2025.130772_bb0485","article-title":"HSP70 chaperones RNA-free TDP-43 into anisotropic intranuclear liquid spherical shells","volume":"371","author":"Yu","year":"2021","journal-title":"Science (1979)"},{"key":"10.1016\/j.bbagen.2025.130772_bb0490","article-title":"Hsp104: a weapon to combat diverse neurodegenerative disorders","volume":"16","author":"Shorter","year":"2007","journal-title":"NeuroSignals"},{"key":"10.1016\/j.bbagen.2025.130772_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.gde.2017.01.008","article-title":"Designer protein disaggregases to counter neurodegenerative disease","volume":"44","author":"Shorter","year":"2017","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.bbagen.2025.130772_bb0500","doi-asserted-by":"crossref","DOI":"10.3390\/cells10020262","article-title":"Mechanisms and therapeutic implications of gsk-3 in treating neurodegeneration","volume":"10","author":"Rippin","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbagen.2025.130772_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.tcb.2016.05.004","article-title":"Principles and properties of stress granules","volume":"26","author":"Protter","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbagen.2025.130772_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118876","article-title":"Molecular mechanisms of stress granule assembly and disassembly","volume":"1868","author":"Hofmann","year":"2021","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.bbagen.2025.130772_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.03.025","article-title":"Stress granule assembly disrupts nucleocytoplasmic transport","volume":"173","author":"Zhang","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.bbagen.2025.130772_bb0520","doi-asserted-by":"crossref","DOI":"10.1038\/nchembio.797","article-title":"Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation","volume":"8","author":"Yuzwa","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbagen.2025.130772_bb0525","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMra1205406","article-title":"Autophagy in human health and disease","volume":"368","author":"Choi","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagen.2025.130772_bb0530","doi-asserted-by":"crossref","DOI":"10.3390\/cells11152262","article-title":"Autophagy: a key regulator of homeostasis and disease: an overview of molecular mechanisms and modulators","volume":"11","author":"G\u00f3mez-Virgilio","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbagen.2025.130772_bb0535","article-title":"KEAP1-NRF2 signalling and autophagy in protection against oxidative and reductive proteotoxicity","volume":"469","author":"M., D., M., R., N.S., R., V., D.-U. & J., Z","year":"2015","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbagen.2025.130772_bb0540","article-title":"Design of the phase 3, randomised, placebo-controlled trial of oral arimoclomol in amyotrophic lateral sclerosis ORARIALS-01","volume":"20","author":"Sundgreen","year":"2019","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"10.1016\/j.bbagen.2025.130772_bb0545","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/bti541","article-title":"IUPred: web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content","volume":"21","author":"Doszt\u00e1nyi","year":"2005","journal-title":"Bioinformatics"}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416525000170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416525000170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T13:13:22Z","timestamp":1740575602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416525000170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":109,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0304416525000170"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2025.130772","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The roles of intrinsically disordered proteins in neurodegeneration","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2025.130772","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"130772"}}